Physician
Neurology
Dr. Patricia A. Walicke, MD
|
|
Give Review
Patricia Walicke works in the field of Neurology. Patricia Walicke is also a published doctor. She has 38 publication published. The most recent publication is: Comparative study of the clinical effectiveness of a pyrethrin-based pediculicide with combing versus a permethrin-based pediculicide with combing.
Publications
- The case for soluble A? oligomers as a drug target in Alzheimer's disease.
- Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis: review of clinical data. part II.
- Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part I.
- Pharmacokinetics and pharmacodynamics of multiple weekly subcutaneous efalizumab doses in patients with plaque psoriasis.
- Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody.
- Determination of transmitter function by neuronal activity.
- Novel neurotrophic factors, receptors, and oncogenes.
- How well do we understand neurotrophic factors and the control of CNS neuronal growth?
- Fibroblast growth factors.
- Neurogenic bladder from occult herpes zoster.
- Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I cl...
- On the role of Ca2+ in the transmitter choice made by cultured sympathetic neurons.
- On the role of cyclic nucleotides in the transmitter choice made by cultured sympathetic neurons.
- Neuropsychological evidence for multiple implicit memory systems: a comparison of Alzheimer's, Huntington's, and Parkinson's disease patients.
- Localization of basic fibroblast growth factor and its mRNA after CNS injury.
- Basic and acidic fibroblast growth factors have trophic effects on neurons from multiple CNS regions.
- Interactions between basic fibroblast growth factor (FGF) and glycosoaminoglycans in promoting neurite outgrowth.
- Trophic effects of fibroblast growth factor on neural tissue.
- Basic fibroblast growth factor (FGF) in the central nervous system: identification of specific loci of basic FGF expression in the rat brain.
- Neurotrophic effects of basic and acidic fibroblast growth factors are not mediated through glial cells.
- Characterization of the neuronal receptor for basic fibroblast growth factor and comparison to receptors on mesenchymal cells.
- Internalization and processing of basic fibroblast growth factor by neurons and astrocytes.
- Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension.
- Migrainous stroke.
- Purification of a human red blood cell protein supporting the survival of cultured CNS neurons, and its identification as catalase.
- The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody.
- Comparative study of the clinical effectiveness of a pyrethrin-based pediculicide with combing versus a permethrin-based pediculicide with combing.
- Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis.
- Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial.
- A novel targeted T-cell modulator, efalizumab, for plaque psoriasis.
- Subcutaneously administered efalizumab (anti-CD11a) improves signs and symptoms of moderate to severe plaque psoriasis.
- Anti-adhesion antibodies efalizumab, a humanized anti-CD11a monoclonal antibody.
- An overview of the pharmacokinetics and pharmacodynamics of efalizumab: a monoclonal antibody approved for use in psoriasis.
- Novel class of pain drugs based on antagonism of NGF.
- Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.
- A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P).
- Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: a phase IIIb, randomized, controlled trial.
Schools
Harvard Medical School
VA Hospital
Montreal Neur Institute McGill University
University Of California San Diego
Doctors Specialties
- Neurology